nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—HTR2B—cardial valve—dilated cardiomyopathy	0.0481	0.517	CbGeAlD
Ropinirole—HTR2A—pulmonary artery—dilated cardiomyopathy	0.0104	0.112	CbGeAlD
Ropinirole—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.0101	0.109	CbGeAlD
Ropinirole—DRD4—heart—dilated cardiomyopathy	0.00724	0.0778	CbGeAlD
Ropinirole—ADRA2C—cardiac ventricle—dilated cardiomyopathy	0.00319	0.0342	CbGeAlD
Ropinirole—ADRA2C—myocardium—dilated cardiomyopathy	0.003	0.0322	CbGeAlD
Ropinirole—HTR2B—heart—dilated cardiomyopathy	0.00266	0.0286	CbGeAlD
Ropinirole—Urine output increased—Furosemide—dilated cardiomyopathy	0.00244	0.0042	CcSEcCtD
Ropinirole—Bladder pain—Furosemide—dilated cardiomyopathy	0.00244	0.0042	CcSEcCtD
Ropinirole—Mental disability—Furosemide—dilated cardiomyopathy	0.00234	0.00403	CcSEcCtD
Ropinirole—Proteinuria—Lisinopril—dilated cardiomyopathy	0.00231	0.00397	CcSEcCtD
Ropinirole—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00229	0.00394	CcSEcCtD
Ropinirole—Protein urine present—Lisinopril—dilated cardiomyopathy	0.00228	0.00392	CcSEcCtD
Ropinirole—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00227	0.0039	CcSEcCtD
Ropinirole—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00225	0.00388	CcSEcCtD
Ropinirole—Viral infection—Lisinopril—dilated cardiomyopathy	0.00224	0.00386	CcSEcCtD
Ropinirole—Polyuria—Furosemide—dilated cardiomyopathy	0.00223	0.00384	CcSEcCtD
Ropinirole—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00223	0.00384	CcSEcCtD
Ropinirole—Alopecia—Spironolactone—dilated cardiomyopathy	0.0022	0.00379	CcSEcCtD
Ropinirole—Oliguria—Lisinopril—dilated cardiomyopathy	0.0022	0.00379	CcSEcCtD
Ropinirole—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00219	0.00377	CcSEcCtD
Ropinirole—Deafness—Furosemide—dilated cardiomyopathy	0.00219	0.00377	CcSEcCtD
Ropinirole—Gout—Lisinopril—dilated cardiomyopathy	0.00217	0.00374	CcSEcCtD
Ropinirole—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00216	0.00371	CcSEcCtD
Ropinirole—ADRA2C—heart—dilated cardiomyopathy	0.00209	0.0225	CbGeAlD
Ropinirole—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00209	0.00359	CcSEcCtD
Ropinirole—Thirst—Furosemide—dilated cardiomyopathy	0.00206	0.00355	CcSEcCtD
Ropinirole—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00205	0.00353	CcSEcCtD
Ropinirole—Neck pain—Lisinopril—dilated cardiomyopathy	0.00205	0.00353	CcSEcCtD
Ropinirole—Purpura—Furosemide—dilated cardiomyopathy	0.00203	0.0035	CcSEcCtD
Ropinirole—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00203	0.00349	CcSEcCtD
Ropinirole—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00203	0.00349	CcSEcCtD
Ropinirole—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00201	0.00347	CcSEcCtD
Ropinirole—Lethargy—Furosemide—dilated cardiomyopathy	0.002	0.00344	CcSEcCtD
Ropinirole—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00199	0.00343	CcSEcCtD
Ropinirole—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00198	0.00341	CcSEcCtD
Ropinirole—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00197	0.00339	CcSEcCtD
Ropinirole—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00197	0.00339	CcSEcCtD
Ropinirole—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00197	0.00339	CcSEcCtD
Ropinirole—Wheezing—Lisinopril—dilated cardiomyopathy	0.00197	0.00339	CcSEcCtD
Ropinirole—Malaise—Spironolactone—dilated cardiomyopathy	0.00196	0.00337	CcSEcCtD
Ropinirole—Cystitis—Lisinopril—dilated cardiomyopathy	0.00196	0.00337	CcSEcCtD
Ropinirole—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00194	0.00334	CcSEcCtD
Ropinirole—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00192	0.00331	CcSEcCtD
Ropinirole—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00191	0.00329	CcSEcCtD
Ropinirole—Photophobia—Lisinopril—dilated cardiomyopathy	0.0019	0.00328	CcSEcCtD
Ropinirole—Neuropathy—Lisinopril—dilated cardiomyopathy	0.0019	0.00328	CcSEcCtD
Ropinirole—Irritability—Furosemide—dilated cardiomyopathy	0.00187	0.00322	CcSEcCtD
Ropinirole—Urinary retention—Furosemide—dilated cardiomyopathy	0.00187	0.00321	CcSEcCtD
Ropinirole—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00183	0.00315	CcSEcCtD
Ropinirole—Discomfort—Spironolactone—dilated cardiomyopathy	0.00183	0.00314	CcSEcCtD
Ropinirole—Dehydration—Furosemide—dilated cardiomyopathy	0.00182	0.00314	CcSEcCtD
Ropinirole—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.0018	0.00311	CcSEcCtD
Ropinirole—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00179	0.00308	CcSEcCtD
Ropinirole—ADRA2C—cardiac atrium—dilated cardiomyopathy	0.00179	0.0192	CbGeAlD
Ropinirole—Confusional state—Spironolactone—dilated cardiomyopathy	0.00179	0.00307	CcSEcCtD
Ropinirole—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00179	0.00307	CcSEcCtD
Ropinirole—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00178	0.00306	CcSEcCtD
Ropinirole—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00177	0.00304	CcSEcCtD
Ropinirole—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00173	0.00299	CcSEcCtD
Ropinirole—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00173	0.00298	CcSEcCtD
Ropinirole—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00171	0.00294	CcSEcCtD
Ropinirole—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.0017	0.00293	CcSEcCtD
Ropinirole—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00169	0.00291	CcSEcCtD
Ropinirole—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00168	0.00289	CcSEcCtD
Ropinirole—ADRA2A—heart—dilated cardiomyopathy	0.00167	0.0179	CbGeAlD
Ropinirole—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00166	0.00286	CcSEcCtD
Ropinirole—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00166	0.00286	CcSEcCtD
Ropinirole—Eczema—Lisinopril—dilated cardiomyopathy	0.00164	0.00282	CcSEcCtD
Ropinirole—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00162	0.00278	CcSEcCtD
Ropinirole—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00159	0.00274	CcSEcCtD
Ropinirole—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00159	0.00273	CcSEcCtD
Ropinirole—Somnolence—Spironolactone—dilated cardiomyopathy	0.00158	0.00271	CcSEcCtD
Ropinirole—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00157	0.00269	CcSEcCtD
Ropinirole—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00155	0.00267	CcSEcCtD
Ropinirole—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00155	0.00266	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00153	0.00263	CcSEcCtD
Ropinirole—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00153	0.00263	CcSEcCtD
Ropinirole—Arthritis—Lisinopril—dilated cardiomyopathy	0.00151	0.00261	CcSEcCtD
Ropinirole—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00151	0.00259	CcSEcCtD
Ropinirole—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00148	0.00254	CcSEcCtD
Ropinirole—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00147	0.00253	CcSEcCtD
Ropinirole—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00147	0.00253	CcSEcCtD
Ropinirole—Diplopia—Lisinopril—dilated cardiomyopathy	0.00147	0.00253	CcSEcCtD
Ropinirole—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00146	0.00251	CcSEcCtD
Ropinirole—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00146	0.00251	CcSEcCtD
Ropinirole—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00143	0.00246	CcSEcCtD
Ropinirole—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.00143	0.0153	CbGeAlD
Ropinirole—Face oedema—Lisinopril—dilated cardiomyopathy	0.00142	0.00244	CcSEcCtD
Ropinirole—HTR2A—heart—dilated cardiomyopathy	0.00142	0.0153	CbGeAlD
Ropinirole—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00141	0.00243	CcSEcCtD
Ropinirole—Urticaria—Spironolactone—dilated cardiomyopathy	0.00141	0.00242	CcSEcCtD
Ropinirole—Irritability—Lisinopril—dilated cardiomyopathy	0.0014	0.00242	CcSEcCtD
Ropinirole—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0014	0.00241	CcSEcCtD
Ropinirole—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.0014	0.00241	CcSEcCtD
Ropinirole—Ataxia—Lisinopril—dilated cardiomyopathy	0.00138	0.00238	CcSEcCtD
Ropinirole—Dehydration—Lisinopril—dilated cardiomyopathy	0.00137	0.00236	CcSEcCtD
Ropinirole—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00134	0.00231	CcSEcCtD
Ropinirole—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00134	0.00231	CcSEcCtD
Ropinirole—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00133	0.00229	CcSEcCtD
Ropinirole—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00133	0.00229	CcSEcCtD
Ropinirole—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00133	0.00228	CcSEcCtD
Ropinirole—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00132	0.00226	CcSEcCtD
Ropinirole—Visual impairment—Furosemide—dilated cardiomyopathy	0.00131	0.00225	CcSEcCtD
Ropinirole—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00131	0.00225	CcSEcCtD
Ropinirole—Gastritis—Lisinopril—dilated cardiomyopathy	0.0013	0.00224	CcSEcCtD
Ropinirole—Influenza—Lisinopril—dilated cardiomyopathy	0.00127	0.00219	CcSEcCtD
Ropinirole—Asthma—Lisinopril—dilated cardiomyopathy	0.00127	0.00219	CcSEcCtD
Ropinirole—Eye disorder—Furosemide—dilated cardiomyopathy	0.00127	0.00218	CcSEcCtD
Ropinirole—Tinnitus—Furosemide—dilated cardiomyopathy	0.00127	0.00218	CcSEcCtD
Ropinirole—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00126	0.00217	CcSEcCtD
Ropinirole—Pruritus—Spironolactone—dilated cardiomyopathy	0.00125	0.00216	CcSEcCtD
Ropinirole—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00125	0.00215	CcSEcCtD
Ropinirole—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00124	0.00213	CcSEcCtD
Ropinirole—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00124	0.00213	CcSEcCtD
Ropinirole—Angiopathy—Furosemide—dilated cardiomyopathy	0.00123	0.00212	CcSEcCtD
Ropinirole—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00123	0.00211	CcSEcCtD
Ropinirole—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00122	0.00211	CcSEcCtD
Ropinirole—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00121	0.00209	CcSEcCtD
Ropinirole—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00121	0.00209	CcSEcCtD
Ropinirole—Dysuria—Lisinopril—dilated cardiomyopathy	0.00119	0.00205	CcSEcCtD
Ropinirole—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00118	0.00203	CcSEcCtD
Ropinirole—Malnutrition—Furosemide—dilated cardiomyopathy	0.00118	0.00203	CcSEcCtD
Ropinirole—Dizziness—Spironolactone—dilated cardiomyopathy	0.00117	0.00202	CcSEcCtD
Ropinirole—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00117	0.00202	CcSEcCtD
Ropinirole—Flatulence—Furosemide—dilated cardiomyopathy	0.00116	0.002	CcSEcCtD
Ropinirole—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00116	0.002	CcSEcCtD
Ropinirole—Weight increased—Lisinopril—dilated cardiomyopathy	0.00116	0.00199	CcSEcCtD
Ropinirole—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00116	0.00199	CcSEcCtD
Ropinirole—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00115	0.00198	CcSEcCtD
Ropinirole—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00115	0.00197	CcSEcCtD
Ropinirole—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00114	0.00196	CcSEcCtD
Ropinirole—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00114	0.00195	CcSEcCtD
Ropinirole—Depression—Lisinopril—dilated cardiomyopathy	0.00113	0.00195	CcSEcCtD
Ropinirole—Vomiting—Spironolactone—dilated cardiomyopathy	0.00113	0.00194	CcSEcCtD
Ropinirole—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00112	0.00192	CcSEcCtD
Ropinirole—Rash—Spironolactone—dilated cardiomyopathy	0.00112	0.00192	CcSEcCtD
Ropinirole—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00112	0.00192	CcSEcCtD
Ropinirole—Vision blurred—Furosemide—dilated cardiomyopathy	0.00111	0.00192	CcSEcCtD
Ropinirole—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00111	0.00191	CcSEcCtD
Ropinirole—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00111	0.00191	CcSEcCtD
Ropinirole—Headache—Spironolactone—dilated cardiomyopathy	0.00111	0.00191	CcSEcCtD
Ropinirole—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.0011	0.0019	CcSEcCtD
Ropinirole—Anaemia—Furosemide—dilated cardiomyopathy	0.00109	0.00188	CcSEcCtD
Ropinirole—Agitation—Furosemide—dilated cardiomyopathy	0.00109	0.00187	CcSEcCtD
Ropinirole—Haematuria—Lisinopril—dilated cardiomyopathy	0.00108	0.00186	CcSEcCtD
Ropinirole—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00107	0.00185	CcSEcCtD
Ropinirole—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00107	0.00184	CcSEcCtD
Ropinirole—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00106	0.00183	CcSEcCtD
Ropinirole—Vertigo—Furosemide—dilated cardiomyopathy	0.00106	0.00183	CcSEcCtD
Ropinirole—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00106	0.00182	CcSEcCtD
Ropinirole—Leukopenia—Furosemide—dilated cardiomyopathy	0.00106	0.00182	CcSEcCtD
Ropinirole—Nausea—Spironolactone—dilated cardiomyopathy	0.00105	0.00181	CcSEcCtD
Ropinirole—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00104	0.00178	CcSEcCtD
Ropinirole—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00102	0.00176	CcSEcCtD
Ropinirole—Hallucination—Lisinopril—dilated cardiomyopathy	0.00101	0.00174	CcSEcCtD
Ropinirole—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00101	0.00174	CcSEcCtD
Ropinirole—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00101	0.00173	CcSEcCtD
Ropinirole—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.001	0.00173	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000999	0.00172	CcSEcCtD
Ropinirole—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000998	0.00172	CcSEcCtD
Ropinirole—Dry mouth—Furosemide—dilated cardiomyopathy	0.000983	0.00169	CcSEcCtD
Ropinirole—Confusional state—Furosemide—dilated cardiomyopathy	0.000972	0.00167	CcSEcCtD
Ropinirole—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000949	0.00163	CcSEcCtD
Ropinirole—Shock—Furosemide—dilated cardiomyopathy	0.000948	0.00163	CcSEcCtD
Ropinirole—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000945	0.00163	CcSEcCtD
Ropinirole—Flushing—Lisinopril—dilated cardiomyopathy	0.000945	0.00163	CcSEcCtD
Ropinirole—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000944	0.00162	CcSEcCtD
Ropinirole—Skin disorder—Furosemide—dilated cardiomyopathy	0.000936	0.00161	CcSEcCtD
Ropinirole—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000932	0.0016	CcSEcCtD
Ropinirole—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000924	0.00159	CcSEcCtD
Ropinirole—Anorexia—Furosemide—dilated cardiomyopathy	0.000919	0.00158	CcSEcCtD
Ropinirole—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000918	0.00158	CcSEcCtD
Ropinirole—Chills—Lisinopril—dilated cardiomyopathy	0.000913	0.00157	CcSEcCtD
Ropinirole—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000909	0.00157	CcSEcCtD
Ropinirole—Hypotension—Furosemide—dilated cardiomyopathy	0.000901	0.00155	CcSEcCtD
Ropinirole—Alopecia—Lisinopril—dilated cardiomyopathy	0.0009	0.00155	CcSEcCtD
Ropinirole—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000892	0.00153	CcSEcCtD
Ropinirole—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000886	0.00153	CcSEcCtD
Ropinirole—Flatulence—Lisinopril—dilated cardiomyopathy	0.000873	0.0015	CcSEcCtD
Ropinirole—Tension—Lisinopril—dilated cardiomyopathy	0.00087	0.0015	CcSEcCtD
Ropinirole—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000868	0.00149	CcSEcCtD
Ropinirole—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000866	0.00149	CcSEcCtD
Ropinirole—Nervousness—Lisinopril—dilated cardiomyopathy	0.000861	0.00148	CcSEcCtD
Ropinirole—Back pain—Lisinopril—dilated cardiomyopathy	0.000857	0.00148	CcSEcCtD
Ropinirole—Somnolence—Furosemide—dilated cardiomyopathy	0.000857	0.00147	CcSEcCtD
Ropinirole—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000852	0.00147	CcSEcCtD
Ropinirole—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000838	0.00144	CcSEcCtD
Ropinirole—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000835	0.00144	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000832	0.00143	CcSEcCtD
Ropinirole—Fatigue—Furosemide—dilated cardiomyopathy	0.000831	0.00143	CcSEcCtD
Ropinirole—Tremor—Lisinopril—dilated cardiomyopathy	0.00083	0.00143	CcSEcCtD
Ropinirole—Pain—Furosemide—dilated cardiomyopathy	0.000824	0.00142	CcSEcCtD
Ropinirole—Constipation—Furosemide—dilated cardiomyopathy	0.000824	0.00142	CcSEcCtD
Ropinirole—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000822	0.00142	CcSEcCtD
Ropinirole—Anaemia—Lisinopril—dilated cardiomyopathy	0.000819	0.00141	CcSEcCtD
Ropinirole—Angioedema—Lisinopril—dilated cardiomyopathy	0.00081	0.00139	CcSEcCtD
Ropinirole—Malaise—Lisinopril—dilated cardiomyopathy	0.000799	0.00138	CcSEcCtD
Ropinirole—Vertigo—Lisinopril—dilated cardiomyopathy	0.000796	0.00137	CcSEcCtD
Ropinirole—Syncope—Lisinopril—dilated cardiomyopathy	0.000795	0.00137	CcSEcCtD
Ropinirole—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000794	0.00137	CcSEcCtD
Ropinirole—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000793	0.00137	CcSEcCtD
Ropinirole—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000788	0.00136	CcSEcCtD
Ropinirole—Palpitations—Lisinopril—dilated cardiomyopathy	0.000783	0.00135	CcSEcCtD
Ropinirole—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000779	0.00134	CcSEcCtD
Ropinirole—Cough—Lisinopril—dilated cardiomyopathy	0.000773	0.00133	CcSEcCtD
Ropinirole—Urticaria—Furosemide—dilated cardiomyopathy	0.000766	0.00132	CcSEcCtD
Ropinirole—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000762	0.00131	CcSEcCtD
Ropinirole—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000762	0.00131	CcSEcCtD
Ropinirole—Myalgia—Lisinopril—dilated cardiomyopathy	0.000755	0.0013	CcSEcCtD
Ropinirole—Chest pain—Lisinopril—dilated cardiomyopathy	0.000755	0.0013	CcSEcCtD
Ropinirole—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000755	0.0013	CcSEcCtD
Ropinirole—Anxiety—Lisinopril—dilated cardiomyopathy	0.000752	0.00129	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000749	0.00129	CcSEcCtD
Ropinirole—Discomfort—Lisinopril—dilated cardiomyopathy	0.000745	0.00128	CcSEcCtD
Ropinirole—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000738	0.00127	CcSEcCtD
Ropinirole—Confusional state—Lisinopril—dilated cardiomyopathy	0.000729	0.00126	CcSEcCtD
Ropinirole—Oedema—Lisinopril—dilated cardiomyopathy	0.000723	0.00124	CcSEcCtD
Ropinirole—Infection—Lisinopril—dilated cardiomyopathy	0.000719	0.00124	CcSEcCtD
Ropinirole—Shock—Lisinopril—dilated cardiomyopathy	0.000712	0.00122	CcSEcCtD
Ropinirole—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00071	0.00122	CcSEcCtD
Ropinirole—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000708	0.00122	CcSEcCtD
Ropinirole—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000706	0.00121	CcSEcCtD
Ropinirole—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000703	0.00121	CcSEcCtD
Ropinirole—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000699	0.0012	CcSEcCtD
Ropinirole—Asthenia—Furosemide—dilated cardiomyopathy	0.000692	0.00119	CcSEcCtD
Ropinirole—Anorexia—Lisinopril—dilated cardiomyopathy	0.000689	0.00119	CcSEcCtD
Ropinirole—Pruritus—Furosemide—dilated cardiomyopathy	0.000682	0.00117	CcSEcCtD
Ropinirole—Hypotension—Lisinopril—dilated cardiomyopathy	0.000676	0.00116	CcSEcCtD
Ropinirole—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00066	0.00114	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000659	0.00113	CcSEcCtD
Ropinirole—Insomnia—Lisinopril—dilated cardiomyopathy	0.000654	0.00113	CcSEcCtD
Ropinirole—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000649	0.00112	CcSEcCtD
Ropinirole—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000645	0.00111	CcSEcCtD
Ropinirole—Somnolence—Lisinopril—dilated cardiomyopathy	0.000643	0.00111	CcSEcCtD
Ropinirole—Dizziness—Furosemide—dilated cardiomyopathy	0.000637	0.0011	CcSEcCtD
Ropinirole—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000637	0.0011	CcSEcCtD
Ropinirole—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000629	0.00108	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000624	0.00107	CcSEcCtD
Ropinirole—Fatigue—Lisinopril—dilated cardiomyopathy	0.000624	0.00107	CcSEcCtD
Ropinirole—Pain—Lisinopril—dilated cardiomyopathy	0.000619	0.00106	CcSEcCtD
Ropinirole—Constipation—Lisinopril—dilated cardiomyopathy	0.000619	0.00106	CcSEcCtD
Ropinirole—Vomiting—Furosemide—dilated cardiomyopathy	0.000613	0.00105	CcSEcCtD
Ropinirole—Rash—Furosemide—dilated cardiomyopathy	0.000608	0.00105	CcSEcCtD
Ropinirole—Dermatitis—Furosemide—dilated cardiomyopathy	0.000607	0.00105	CcSEcCtD
Ropinirole—Headache—Furosemide—dilated cardiomyopathy	0.000604	0.00104	CcSEcCtD
Ropinirole—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000596	0.00103	CcSEcCtD
Ropinirole—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000591	0.00102	CcSEcCtD
Ropinirole—Urticaria—Lisinopril—dilated cardiomyopathy	0.000575	0.000989	CcSEcCtD
Ropinirole—Nausea—Furosemide—dilated cardiomyopathy	0.000573	0.000985	CcSEcCtD
Ropinirole—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000572	0.000984	CcSEcCtD
Ropinirole—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000572	0.000984	CcSEcCtD
Ropinirole—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000533	0.000917	CcSEcCtD
Ropinirole—Asthenia—Lisinopril—dilated cardiomyopathy	0.000519	0.000893	CcSEcCtD
Ropinirole—Pruritus—Lisinopril—dilated cardiomyopathy	0.000512	0.000881	CcSEcCtD
Ropinirole—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000495	0.000852	CcSEcCtD
Ropinirole—Dizziness—Lisinopril—dilated cardiomyopathy	0.000478	0.000823	CcSEcCtD
Ropinirole—Vomiting—Lisinopril—dilated cardiomyopathy	0.00046	0.000791	CcSEcCtD
Ropinirole—Rash—Lisinopril—dilated cardiomyopathy	0.000456	0.000785	CcSEcCtD
Ropinirole—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000456	0.000784	CcSEcCtD
Ropinirole—Headache—Lisinopril—dilated cardiomyopathy	0.000453	0.00078	CcSEcCtD
Ropinirole—Nausea—Lisinopril—dilated cardiomyopathy	0.00043	0.000739	CcSEcCtD
Ropinirole—HTR1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.5e-05	0.000292	CbGpPWpGaD
Ropinirole—DRD3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	9.43e-05	0.000289	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.4e-05	0.000288	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—AGT—dilated cardiomyopathy	9.36e-05	0.000287	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.35e-05	0.000287	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	9.33e-05	0.000286	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.3e-05	0.000286	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.3e-05	0.000285	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—AGT—dilated cardiomyopathy	9.21e-05	0.000283	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.2e-05	0.000283	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.2e-05	0.000282	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	9.18e-05	0.000282	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.15e-05	0.000281	CbGpPWpGaD
Ropinirole—DRD1—GPCR downstream signaling—AGT—dilated cardiomyopathy	9.13e-05	0.00028	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	9.08e-05	0.000279	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.05e-05	0.000278	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.05e-05	0.000278	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.05e-05	0.000278	CbGpPWpGaD
Ropinirole—DRD3—GPCR downstream signaling—AGT—dilated cardiomyopathy	9.01e-05	0.000277	CbGpPWpGaD
Ropinirole—ADRA2B—Hemostasis—RAF1—dilated cardiomyopathy	8.93e-05	0.000274	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—AGTR2—dilated cardiomyopathy	8.93e-05	0.000274	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CXCL2—dilated cardiomyopathy	8.93e-05	0.000274	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.92e-05	0.000274	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.9e-05	0.000273	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—AGT—dilated cardiomyopathy	8.79e-05	0.00027	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	8.77e-05	0.000269	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.77e-05	0.000269	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.75e-05	0.000269	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.72e-05	0.000268	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.68e-05	0.000266	CbGpPWpGaD
Ropinirole—DRD5—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.66e-05	0.000266	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.64e-05	0.000265	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.56e-05	0.000263	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.54e-05	0.000262	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.51e-05	0.000261	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.48e-05	0.00026	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.44e-05	0.000259	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.42e-05	0.000258	CbGpPWpGaD
Ropinirole—ADRA2C—Hemostasis—RAF1—dilated cardiomyopathy	8.34e-05	0.000256	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	8.33e-05	0.000256	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	8.32e-05	0.000255	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.31e-05	0.000255	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.3e-05	0.000255	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	8.29e-05	0.000255	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.22e-05	0.000252	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—AGT—dilated cardiomyopathy	8.18e-05	0.000251	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.18e-05	0.000251	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.15e-05	0.00025	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	8.13e-05	0.00025	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	8.06e-05	0.000248	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	8.06e-05	0.000248	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.04e-05	0.000247	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.03e-05	0.000246	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	7.96e-05	0.000244	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.95e-05	0.000244	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.86e-05	0.000241	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.85e-05	0.000241	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	7.83e-05	0.00024	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.81e-05	0.00024	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.78e-05	0.000239	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.78e-05	0.000239	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.74e-05	0.000238	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.74e-05	0.000238	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.73e-05	0.000237	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.73e-05	0.000237	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—RAC1—dilated cardiomyopathy	7.72e-05	0.000237	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.7e-05	0.000236	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.61e-05	0.000234	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.6e-05	0.000233	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.57e-05	0.000233	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.56e-05	0.000232	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.53e-05	0.000231	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.53e-05	0.000231	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.5e-05	0.00023	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.46e-05	0.000229	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.46e-05	0.000229	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.43e-05	0.000228	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	7.39e-05	0.000227	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.38e-05	0.000227	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—AGT—dilated cardiomyopathy	7.37e-05	0.000226	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.34e-05	0.000225	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.26e-05	0.000223	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.24e-05	0.000222	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.22e-05	0.000222	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.22e-05	0.000222	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.2e-05	0.000221	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	7.13e-05	0.000219	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.1e-05	0.000218	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	7.09e-05	0.000218	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	7.08e-05	0.000217	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.01e-05	0.000215	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	7e-05	0.000215	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	7e-05	0.000215	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.97e-05	0.000214	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.96e-05	0.000214	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	6.9e-05	0.000212	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.89e-05	0.000212	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	6.89e-05	0.000212	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.87e-05	0.000211	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.84e-05	0.00021	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.84e-05	0.00021	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.78e-05	0.000208	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.78e-05	0.000208	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	6.78e-05	0.000208	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.73e-05	0.000206	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.73e-05	0.000206	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.63e-05	0.000204	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.6e-05	0.000203	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.55e-05	0.000201	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.54e-05	0.000201	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.52e-05	0.0002	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.5e-05	0.000199	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.46e-05	0.000198	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.45e-05	0.000198	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.41e-05	0.000197	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.39e-05	0.000196	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.35e-05	0.000195	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.3e-05	0.000194	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	6.26e-05	0.000192	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.25e-05	0.000192	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.2e-05	0.00019	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.17e-05	0.000189	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	6.16e-05	0.000189	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.15e-05	0.000189	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.12e-05	0.000188	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.12e-05	0.000188	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.1e-05	0.000187	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.06e-05	0.000186	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.02e-05	0.000185	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.99e-05	0.000184	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.96e-05	0.000183	CbGpPWpGaD
Ropinirole—DRD5—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.94e-05	0.000182	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—RAC1—dilated cardiomyopathy	5.91e-05	0.000181	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.88e-05	0.000181	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.87e-05	0.00018	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.79e-05	0.000178	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	5.79e-05	0.000178	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.76e-05	0.000177	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—RAC1—dilated cardiomyopathy	5.7e-05	0.000175	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.69e-05	0.000175	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.68e-05	0.000174	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.68e-05	0.000174	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.68e-05	0.000174	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.65e-05	0.000173	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—AGT—dilated cardiomyopathy	5.65e-05	0.000173	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	5.6e-05	0.000172	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.6e-05	0.000172	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.6e-05	0.000172	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	5.56e-05	0.000171	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—AGT—dilated cardiomyopathy	5.53e-05	0.00017	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.51e-05	0.000169	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.5e-05	0.000169	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.45e-05	0.000167	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—AGT—dilated cardiomyopathy	5.44e-05	0.000167	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—RAC1—dilated cardiomyopathy	5.44e-05	0.000167	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	5.41e-05	0.000166	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.26e-05	0.000161	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—AGT—dilated cardiomyopathy	5.19e-05	0.000159	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.17e-05	0.000159	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	5.13e-05	0.000157	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.13e-05	0.000157	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—RAF1—dilated cardiomyopathy	5.12e-05	0.000157	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—RAC1—dilated cardiomyopathy	5.06e-05	0.000155	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.06e-05	0.000155	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.99e-05	0.000153	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.95e-05	0.000152	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.92e-05	0.000151	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.91e-05	0.000151	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.91e-05	0.000151	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—AGT—dilated cardiomyopathy	4.9e-05	0.00015	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.88e-05	0.00015	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	4.87e-05	0.00015	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.85e-05	0.000149	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—AGT—dilated cardiomyopathy	4.83e-05	0.000148	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.79e-05	0.000147	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.72e-05	0.000145	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.71e-05	0.000144	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	4.57e-05	0.00014	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.55e-05	0.00014	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	4.52e-05	0.000139	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.46e-05	0.000137	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.46e-05	0.000137	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	4.41e-05	0.000135	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	4.4e-05	0.000135	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	4.39e-05	0.000135	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.38e-05	0.000135	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	4.36e-05	0.000134	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.35e-05	0.000133	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.28e-05	0.000132	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.28e-05	0.000131	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	4.27e-05	0.000131	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.22e-05	0.000129	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	4.21e-05	0.000129	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	4.19e-05	0.000129	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.18e-05	0.000128	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	4.08e-05	0.000125	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	3.96e-05	0.000122	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.95e-05	0.000121	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—RAF1—dilated cardiomyopathy	3.92e-05	0.00012	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.89e-05	0.00012	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.89e-05	0.000119	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	3.87e-05	0.000119	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	3.84e-05	0.000118	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.84e-05	0.000118	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	3.81e-05	0.000117	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—RAF1—dilated cardiomyopathy	3.78e-05	0.000116	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	3.7e-05	0.000114	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	3.64e-05	0.000112	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—RAF1—dilated cardiomyopathy	3.61e-05	0.000111	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.52e-05	0.000108	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—EGFR—dilated cardiomyopathy	3.51e-05	0.000108	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	3.47e-05	0.000106	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	3.4e-05	0.000104	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.39e-05	0.000104	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.38e-05	0.000104	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—RAF1—dilated cardiomyopathy	3.35e-05	0.000103	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	3.31e-05	0.000102	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.28e-05	0.000101	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	3.03e-05	9.3e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.98e-05	9.15e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	2.94e-05	9.03e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.93e-05	9e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.92e-05	8.97e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	2.91e-05	8.93e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	2.87e-05	8.8e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	2.83e-05	8.68e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—EGFR—dilated cardiomyopathy	2.69e-05	8.25e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.67e-05	8.19e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	2.63e-05	8.08e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—EGFR—dilated cardiomyopathy	2.59e-05	7.95e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	2.58e-05	7.92e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	2.57e-05	7.88e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.53e-05	7.75e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	2.49e-05	7.65e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—EGFR—dilated cardiomyopathy	2.47e-05	7.59e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	2.43e-05	7.45e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.33e-05	7.16e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—EGFR—dilated cardiomyopathy	2.3e-05	7.06e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.3e-05	7.05e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	2.19e-05	6.71e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	2.08e-05	6.37e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	2e-05	6.15e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	1.99e-05	6.12e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	1.94e-05	5.95e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.92e-05	5.91e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.87e-05	5.75e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.76e-05	5.4e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.73e-05	5.32e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.69e-05	5.18e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.58e-05	4.84e-05	CbGpPWpGaD
